BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 15205330)

  • 21. Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain.
    Palmieri D; Bronder JL; Herring JM; Yoneda T; Weil RJ; Stark AM; Kurek R; Vega-Valle E; Feigenbaum L; Halverson D; Vortmeyer AO; Steinberg SM; Aldape K; Steeg PS
    Cancer Res; 2007 May; 67(9):4190-8. PubMed ID: 17483330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. S100A2 induces metastasis in non-small cell lung cancer.
    Bulk E; Sargin B; Krug U; Hascher A; Jun Y; Knop M; Kerkhoff C; Gerke V; Liersch R; Mesters RM; Hotfilder M; Marra A; Koschmieder S; Dugas M; Berdel WE; Serve H; Müller-Tidow C
    Clin Cancer Res; 2009 Jan; 15(1):22-9. PubMed ID: 19118029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNAi-mediated A disintegrin and metalloproteinase 9 gene silencing inhibits the tumor growth of non-small lung cancer in vitro and in vivo.
    Chang L; Gong F; Cui Y
    Mol Med Rep; 2015 Jul; 12(1):1197-204. PubMed ID: 25778452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of ADAM9 in multinucleated giant cell formation of blood monocytes.
    Namba K; Nishio M; Mori K; Miyamoto N; Tsurudome M; Ito M; Kawano M; Uchida A; Ito Y
    Cell Immunol; 2001 Nov; 213(2):104-13. PubMed ID: 11831872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Introduction of basic fibroblast growth factor gene into mouse renal cell carcinoma cell line enhances its metastatic potential.
    Miyake H; Hara I; Yoshimura K; Eto H; Arakawa S; Wada S; Chihara K; Kamidono S
    Cancer Res; 1996 May; 56(10):2440-5. PubMed ID: 8625325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidative stress induces ADAM9 protein expression in human prostate cancer cells.
    Sung SY; Kubo H; Shigemura K; Arnold RS; Logani S; Wang R; Konaka H; Nakagawa M; Mousses S; Amin M; Anderson C; Johnstone P; Petros JA; Marshall FF; Zhau HE; Chung LW
    Cancer Res; 2006 Oct; 66(19):9519-26. PubMed ID: 17018608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.
    Zhang W; Chen Y; Wei H; Zheng C; Sun R; Zhang J; Tian Z
    Clin Cancer Res; 2008 Oct; 14(20):6432-9. PubMed ID: 18927282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
    Wu YH; Cheng YW; Chang JT; Wu TC; Chen CY; Lee H
    Cancer; 2007 Jul; 110(1):215-23. PubMed ID: 17508409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TMPRSS4 promotes invasion, migration and metastasis of human tumor cells by facilitating an epithelial-mesenchymal transition.
    Jung H; Lee KP; Park SJ; Park JH; Jang YS; Choi SY; Jung JG; Jo K; Park DY; Yoon JH; Park JH; Lim DS; Hong GR; Choi C; Park YK; Lee JW; Hong HJ; Kim S; Park YW
    Oncogene; 2008 Apr; 27(18):2635-47. PubMed ID: 17968309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Semaphorin SEMA3F affects multiple signaling pathways in lung cancer cells.
    Potiron VA; Sharma G; Nasarre P; Clarhaut JA; Augustin HG; Gemmill RM; Roche J; Drabkin HA
    Cancer Res; 2007 Sep; 67(18):8708-15. PubMed ID: 17875711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-associated antigen L6 and the invasion of human lung cancer cells.
    Kao YR; Shih JY; Wen WC; Ko YP; Chen BM; Chan YL; Chu YW; Yang PC; Wu CW; Roffler SR
    Clin Cancer Res; 2003 Jul; 9(7):2807-16. PubMed ID: 12855661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MAG-2 promotes invasion, mobility and adherence capability of lung cancer cells by MMP-2, CD44 and intracellular calcium in vitro.
    Zhang J; Liu G; Meng Y; Lin H; Lu Y
    Oncol Rep; 2009 Mar; 21(3):697-706. PubMed ID: 19212629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
    Katiyar SK; Meeran SM; Katiyar N; Akhtar S
    Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Critical function for ADAM9 in mouse prostate cancer.
    Peduto L; Reuter VE; Shaffer DR; Scher HI; Blobel CP
    Cancer Res; 2005 Oct; 65(20):9312-9. PubMed ID: 16230393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
    Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
    Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cyclin D1 regulates lung cancer invasion and metastasis].
    Li ZL; Shao SH; Jiao F; Yue Z; Ma Y
    Sheng Li Xue Bao; 2012 Feb; 64(1):55-61. PubMed ID: 22348961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reactive oxygen species mediate androgen receptor- and serum starvation-elicited downstream signaling of ADAM9 expression in human prostate cancer cells.
    Shigemura K; Sung SY; Kubo H; Arnold RS; Fujisawa M; Gotoh A; Zhau HE; Chung LW
    Prostate; 2007 May; 67(7):722-31. PubMed ID: 17342749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant alternative exon use and increased copy number of human metalloprotease-disintegrin ADAM15 gene in breast cancer cells.
    Ortiz RM; Kärkkäinen I; Huovila AP
    Genes Chromosomes Cancer; 2004 Dec; 41(4):366-78. PubMed ID: 15384173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines.
    Crawford M; Brawner E; Batte K; Yu L; Hunter MG; Otterson GA; Nuovo G; Marsh CB; Nana-Sinkam SP
    Biochem Biophys Res Commun; 2008 Sep; 373(4):607-12. PubMed ID: 18602365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Up-regulation of Flotillin-2 is associated with melanoma progression and modulates expression of the thrombin receptor protease activated receptor 1.
    Hazarika P; McCarty MF; Prieto VG; George S; Babu D; Koul D; Bar-Eli M; Duvic M
    Cancer Res; 2004 Oct; 64(20):7361-9. PubMed ID: 15492257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.